Perfil
Jennifer Zibuda worked as a Director of Investor Relations & Communications at Prothena Corp.
Plc from 2020 to 2023.
Prior to that, she worked as an Investor Relations Contact at Portola Pharmaceuticals, Inc. and as the Head of Corporate Communications at Alkermes Plc.
Antiguos cargos conocidos de Jennifer Zibuda.
| Empresas | Cargo | Fin |
|---|---|---|
| PROTHENA CORPORATION PLC | Contacto de Relaciones con Inversores | 01/01/2023 |
| ALKERMES PLC | Public Communications Contact | 01/06/2018 |
| PORTOLA PHARMACEUTICALS, INC. | Contacto de Relaciones con Inversores | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ALKERMES PLC | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jennifer Zibuda
